Authors
Loading...
This study evaluates antimicrobial properties of actinomycetes against E. coli and K. pneumoniae, suggesting they may support drug development.
Majhool et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: